Renovis, Inc.

Biopharma company appoints member to board

Published in Lab Law Weekly, August 19th, 2005

Renovis, Inc., (RNVS) announced that Judith A. Hemberger, PhD, executive vice president and chief operating officer and director of Pharmion Corporation (PHRM), has been appointed to its board of directors.

Hemberger joins the board as Edward M. Scolnick, MD, who has served on the company's board since August 2001, resigns to focus on his responsibilities as director of the Psychiatric Disease Initiative at the Broad Institute of MIT. Scolnick will continue to advise Renovis on scientific matters as a member of the company's Medical and scientific advisory board (MSAB). Renovis' board of directors remains at nine members.

"We are grateful to Scolnick...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2005-08-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry